USD
$0.00
(0.00%
)At Close (As of Dec 15, 2025)
$12.31M
Market Cap
-
P/E Ratio
-4.52
EPS
$5.00
52 Week High
$1.78
52 Week Low
TECHNOLOGY
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | -$32K |
| Total Revenue | $21K |
| Cost Of Revenue | $53K |
| Costof Goods And Services Sold | $53K |
| Operating Income | -$14M |
| Selling General And Administrative | $5.4M |
| Research And Development | $8.4M |
| Operating Expenses | $14M |
| Investment Income Net | - |
| Net Interest Income | -$616K |
| Interest Income | - |
| Interest Expense | $616K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $4.8M |
| Income Before Tax | -$15M |
| Income Tax Expense | $800 |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$15M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$14M |
| Ebitda | -$9.4M |
| Net Income | -$15M |
| Field | Value (USD) |
|---|---|
| Total Assets | $29M |
| Total Current Assets | $4.3M |
| Cash And Cash Equivalents At Carrying Value | $3.9M |
| Cash And Short Term Investments | $3.9M |
| Inventory | $144K |
| Current Net Receivables | $56 |
| Total Non Current Assets | $24M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $24M |
| Intangible Assets Excluding Goodwill | $24M |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $301K |
| Other Non Current Assets | - |
| Total Liabilities | $13M |
| Total Current Liabilities | $4M |
| Current Accounts Payable | - |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $3M |
| Total Non Current Liabilities | $9.3M |
| Capital Lease Obligations | - |
| Long Term Debt | $9M |
| Current Long Term Debt | $3M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $12M |
| Other Current Liabilities | $849K |
| Other Non Current Liabilities | $349K |
| Total Shareholder Equity | $16M |
| Treasury Stock | - |
| Retained Earnings | -$53M |
| Common Stock | $154K |
| Common Stock Shares Outstanding | $9.5M |
| Field | Value (USD) |
|---|---|
| Gross Profit | -$32K |
| Total Revenue | $21K |
| Cost Of Revenue | $53K |
| Costof Goods And Services Sold | $53K |
| Operating Income | -$14M |
| Selling General And Administrative | $5.4M |
| Research And Development | $8.4M |
| Operating Expenses | $14M |
| Investment Income Net | - |
| Net Interest Income | -$616K |
| Interest Income | - |
| Interest Expense | $616K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $4.8M |
| Income Before Tax | -$15M |
| Income Tax Expense | $800 |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$15M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$14M |
| Ebitda | -$9.4M |
| Net Income | -$15M |
Sector: TECHNOLOGY
Industry: SCIENTIFIC & TECHNICAL INSTRUMENTS
Ainos, Inc. is an innovative healthcare firm based in San Diego, California, focused on advancing point-of-care testing and treatment solutions to address critical unmet medical needs. By leveraging cutting-edge research and development, Ainos aims to transform healthcare diagnostics and therapeutic interventions across multiple disease areas. As a key player in the evolving healthcare landscape, the company is committed to enhancing patient outcomes and supporting healthcare providers through its reliable and forward-thinking medical technologies.